Inactive Instrument

Achiko AG

ACHI

CH0522213468

Financial Technology (Fintech)

Achiko AG Expects to Have AptameX in Widespread Commercial Availability in Third Quarter of 2022

May 17, 2022 at 12:45 am EDT

Achiko AG expected to have AptameX in widespread commercial availability in third quarter of 2022.

Latest news about Achiko AG

Achiko AG(SWX:ACHI) dropped from Swiss Performance Index (Price Return)	23-10-25	CI
Liquidation-led Achiko's Delisting Gets Regulatory Nod	23-07-25	MT
Achiko, IGEA, Talenthouse Shares Suspended from Trading on SIX Swiss Exchange	23-06-01	MT
Achiko Sees No Demand Change for Rapid COVID-19 Test Despite Production Delays	22-12-21	MT
Achiko AG Provides Updates on Test Performance	22-12-20	CI
Achiko Ag Commences Commercial Deliveries in Indonesia	22-11-14	CI
Achiko Begins Commercial Deliveries Of AptameX COVID-19 Test Kit In Indonesia	22-11-14	MT
Achiko AG Completes Production Test with PT Indofarma Tbk as a Precursor to Mass Production of Its Generation 2 AptameX Covid-19 Test Kit	22-11-02	CI
Achiko Nears Mass Production of AptameX COVID-19 Test Kit	22-11-02	MT
Achiko AG Announces Chief Financial Officer Changes	22-10-07	CI
Healthcare Technology Group Achiko Names New CFO	22-10-07	MT
Achiko's H1 Loss Shrinks Amid Lower Expenses	22-10-03	MT
Swiss Diagnostic Testing Group Achiko's CEO Resigns	22-09-06	MT
Achiko Resumes Trading on SIX Exchange After Obtaining $1 Million Financing	22-09-06	MT
Achiko AG announced that it has received CHF 1.3 million in funding from Buranto AG	22-09-05	CI
Achiko AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Achiko Shares Suspended From Trading On SIX Exchange	22-06-28	MT
Swiss Diagnostic Testing Group Achiko's FY21 Loss Shrinks on Lower Expenses	22-06-27	MT
Global markets live: Hermes, Tesla, Apple, Intel, Visa...	22-06-21
Achiko AG Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-20	CI
Achiko AG Appoints Derek Brand to Advisory Board	22-05-25	CI
Achiko AG Secures $1.3 Million Financing with Strategic Investors Buranto AG and Negma Group	22-05-25	CI
Achiko AG announced that it expects to receive CHF 1.25 million in funding from Negma Group Ltd., Buranto AG	22-05-24	CI
Achiko Preliminarily Expects FY21 Loss as Annual Report Delayed by Pandemic, Staffing	22-05-19	MT
Achiko Receives CE Mark For COVID-19 Rapid Test Allowing Sales In EU Countries	22-05-17	MT

Achiko AG is a Switzerland-based company active in software industry. The Company is primarily engaged in developing Mobile Digital Passporting Service for Covid-19 Management. Company's portfolio includes two products: Teleman Sehat is a payment and booking management and diagnostic testing app for Covid-19 and AptameX is product of a DNA aptamer platform technology with the objective of developing transformational diagnostics.

Sector

Financial Technology (Fintech)

Calendar

2024-04-29 - Q4 2023 Earnings Release (Projected)

More about the company

Sector Financial Technology (Fintech) (NEC)

	1st Jan change	Capi.
INTUIT INC.	+0.22%	178B
ADYEN N.V.	-0.82%	47.04B
FIDELITY NATIONAL INFORMATION SERVICES, INC.	+17.31%	40.82B
ROBINHOOD MARKETS, INC.	+34.38%	15.14B
AFFIRM HOLDINGS, INC.	-35.59%	9.84B
FUTU HOLDINGS LIMITED	+15.32%	8.82B
HITHINK ROYALFLUSH INFORMATION NETWORK CO., LTD.	-29.22%	8.37B
PB FINTECH LIMITED	+58.93%	6.59B
STONECO LTD.	-13.64%	4.89B

Financial Technology (Fintech) (NEC)

Achiko AG

Equities

ACHI

CH0522213468

Financial Technology (Fintech)

Achiko AG Expects to Have AptameX in Widespread Commercial Availability in Third Quarter of 2022

Latest news about Achiko AG

Chart Achiko AG

Company Profile

Sector Financial Technology (Fintech) (NEC)